Figure 7.
RCSD1 differential expression in LUAD with different clinical subgroups. On (A) sample types, (B) individual cancer stages, (C) patient’s race, (D) patient’s gender, (E) patient’s age, (F) patient’s smoking habits, (G) histological subtypes, (H) nodal metastasis status and (I) TP53 mutation status. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
